SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-23-007994
Filing Date
2023-03-15
Accepted
2023-03-15 09:17:58
Documents
5
Effectiveness Date
2023-03-15

Document Format Files

Seq Description Document Type Size
1 S-8 march_2023_s-8.htm S-8 176017
2 EX-5.1 prld-ex5_1.htm EX-5 21478
3 EX-23.2 prld-ex23_2.htm EX-23 4038
4 EX-FILING FEES prld-exfiling_fees.htm EX-FILING FEES 36338
5 GRAPHIC img162401780_0.jpg GRAPHIC 11561
  Complete submission text file 0000950170-23-007994.txt   255003
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270549 | Film No.: 23733494
SIC: 2834 Pharmaceutical Preparations